Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Analysis of oxidative stress in zebrafish embryos.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
The role of stress-response systems for the pathogenesis and progression of MS.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
New management algorithms in multiple sclerosis.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
A bird's-eye view of T cells during natalizumab therapy.
Averting inflammation by targeting the cytokine environment.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Origin and evolution of deep brain stimulation.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Aspirin and multiple sclerosis.
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Pages
« first
‹ previous
…
184
185
186
187
188
189
190
191
192
…
next ›
last »